4//SEC Filing
Dietz Thomas John 4
Accession 0001104659-24-009030
CIK 0001509745other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 9:36 PM ET
Size
5.9 KB
Accession
0001104659-24-009030
Insider Transaction Report
Form 4
Dietz Thomas John
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-01-29+30,000→ 30,000 totalExercise: $2.68Exp: 2034-01-29→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.
Documents
Issuer
LEAP THERAPEUTICS, INC.
CIK 0001509745
Entity typeother
Related Parties
1- filerCIK 0001574218
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 9:36 PM ET
- Size
- 5.9 KB